Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

New research from the Heather Group has shown that in type 2 diabetes an overload of lipids reduces the heart’s ability to generate energy during a heart attack, decreasing chances of recovery.

A graph showing the energy within a beating heart, in the form of Phosphocreatine (PCr) and the three phosphate peaks within Adenosine Triphosphate (ATP). At the beginning, these peaks are rising high. At 12 minutes, the heart is given a heart attack, and the peaks start to drop - firstly the PCr (the energy buffer) is lost from the heart, followed slowly by the three ATP peaks over the subsequent minutes. This shows the profile of energy starvation in a heart during a heart attack.
The heart losing its energy during a heart attack in real time

In patients with type 2 diabetes, the heart becomes starved of energy, leading to decreased recovery in the event of a heart attack. Diabetes is associated with high blood glucose and high blood lipids. Diabetes research tends to focus on the effects of high glucose, but changes in glucose concentrations do not explain why there is an energy deficit in the heart in type 2 diabetes.

It is known that the heart becomes laden with lipids in diabetes. Yet, there have been very few studies investigating the consequences of these high levels of lipids in the heart. Neither the specific lipids causing the metabolic upheaval that leads to energy starvation in the heart, nor the signalling pathways on which they are exerting these effects, have been identified.

New research from the Heather Group has interrogated whether the overload of lipids in the heart could be influencing the energy generation by the heart’s mitochondria. Researchers have found that a specific fatty acid intermediate called Palmitoyl CoA, an 'activated' form of palmitic acid, can regulate the phosphorylation apparatus within the mitochondria, but this regulation is lost in the lipid-loaded environment within the diabetic heart. According to lead researcher Associate Professor Lisa Heather“This has negative consequences for the diabetic heart during ischaemia, as this regulation allows the healthy heart to shut down wasteful ATP breakdown during ischaemia, but this preservation of precious ATP is lost in diabetes.  This may contribute to why patients with diabetes do significantly worse during a heart attack.”

Consequently, the team have demonstrated the necessity of focusing research efforts on the high levels of lipids in the circulation that disrupt a large number of process in the heart. They also demonstrate that targeting this lipid overload is a valid therapeutic target for the diabetic heart. Prof Heather said: “The therapeutic challenge lies in finding the ‘Goldilocks zone’ - we need lipids to provide the energy to keep the heart beating, but it's when we have too much that we see the negative effects as in diabetes. Too much or too little fat is bad for the heart, so we need to find a therapeutic approach that gets it just right!”

The full paper “Diabetic mitochondria are resistant to palmitoyl CoA inhibition of respiration, which is detrimental during ischaemia” is available to read in The FASEB Journal.

The paper is also featured in the i Newspaper both online and in print: New discovery could help diabetics avoid lasting heart attack damage (inews.co.uk)

Similar stories

New book expands the horizons of brain research

A pioneering book from Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch to be released on 1 February 2022 addresses the fundamental relationship between the body, brain and behaviour.

Christoph Treiber awarded ERC Starting Grant to investigate the origins of behavioural diversity

Congratulations are in order for postdoctoral research scientist Dr Christoph Treiber who has been awarded a Starting Grant from the European Research Council. His funded project will investigate the genetic components that may contribute to diversity of brain function and behaviour.

Switch with a spring: a new model for sleep regulation

New collaborative research led by the Vyazovskiy Group has shed new light on the role of the hypothalamus in the transition between sleep and wake states.

Oxford-led research maps milestone stage of human development for the first time

Scientists have shed light on an important stage of early embryonic development that has never been fully mapped out in humans before.

Mapping uncharted networks in the progression of Parkinson’s

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.